Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2002
10/17/2002WO2002081735A2 Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives
10/17/2002WO2002081734A1 Methods for modeling infectious disease and chemosensitivity in cultured cells and tissues
10/17/2002WO2002081730A2 Trac1: modulators of lymphocyte activation
10/17/2002WO2002081729A2 Nucleic acid amplification utilizing microfluidic devices
10/17/2002WO2002081704A2 Regulation of human protein kinase-like protein
10/17/2002WO2002081703A2 Mitogenic oxygenase regulators
10/17/2002WO2002081701A1 Fungal polynucleotide array
10/17/2002WO2002081687A2 Yeast genes that affect viral replication
10/17/2002WO2002081678A2 Method of separating alleles
10/17/2002WO2002081672A1 Bacterial adpglucose pyrophosphatase, method for obtaining the latter and its use in the production of assay devices and in the obtention of transgenic plants and bacteria
10/17/2002WO2002081669A1 Assay methods for o-g1cnac transferase activity
10/17/2002WO2002081665A2 Implantation serine proteinases
10/17/2002WO2002081662A1 Methods and gel compositions for encapsulating living cells and organic molecules
10/17/2002WO2002081656A2 Enhanced diagnostic potential of prostate-specific antigen expressing cells
10/17/2002WO2002081652A2 Use of yacm and yqej, essential bacterial genes and polypeptides and their use
10/17/2002WO2002081646A2 Epitope sequences
10/17/2002WO2002081644A2 Haplotyping method for multiple distal nucleotide polymorphisms
10/17/2002WO2002081642A2 Gene brcc-3 and diagnostic and therapeutic uses thereof
10/17/2002WO2002081639A2 Gene brcc2 and diagnostic and therapeutic uses thereof
10/17/2002WO2002081638A2 Prostate cancer expression profiles
10/17/2002WO2002081636A2 Protein modification and maintenance molecules
10/17/2002WO2002081634A2 Imaging nucleic acid delivery
10/17/2002WO2002081630A2 Use of semenogelin in the diagnosis, prognosis and treatment of cancer
10/17/2002WO2002081627A2 Methods of screening and using inhibitors of angiogenesis
10/17/2002WO2002081624A2 Functional genetic tests of dna mismatch repair
10/17/2002WO2002081513A2 Disease-associated protein
10/17/2002WO2002081494A1 Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
10/17/2002WO2002081492A1 Human gene critical to fertility
10/17/2002WO2002081490A2 Computer-directed assembly of a polynucleotide encoding a target polypeptide
10/17/2002WO2002081476A1 Thiophosphate nucleic acid-based compounds
10/17/2002WO2002081415A2 Method for inhibiting metap2
10/17/2002WO2002081398A2 Additives for building industry obtained from by-products and process for their production
10/17/2002WO2002081164A1 Inventory management system
10/17/2002WO2002081084A2 Microtiter plate format device and methods for separating differently charged molecules using an electric field
10/17/2002WO2002080956A2 Use of compounds modulating rxr-ppar heterodimer activity as medicine for treating hepatitis c
10/17/2002WO2002080955A1 Stimulation of osteogenesis using rank ligand fusion proteins
10/17/2002WO2002080952A2 Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways
10/17/2002WO2002080927A1 Use of selective cox-2 inhibitors for the treatment of urinary incontinence
10/17/2002WO2002080845A2 Novel eps8 compounds for therapy and diagnosis and methods for using same
10/17/2002WO2002080844A2 Novel bgp compounds for therapy and diagnosis and methods for using same
10/17/2002WO2002080758A2 Methods for treating drug addiction
10/17/2002WO2002080755A2 Kits and methods for assessing oxidative stress
10/17/2002WO2002068672A3 Antisense modulation of recql4 expression
10/17/2002WO2002066676A3 Method for qualitative and quantitative analysis of a population of nucleic acids contained in a sample
10/17/2002WO2002063036A3 Vector system used in screening active substances
10/17/2002WO2002060924A3 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds
10/17/2002WO2002053764A3 Hydrophilic polymeric material for coating biosensors
10/17/2002WO2002042440A3 Regulation of plant growth by modifying the expression of a putative trna-isope ntenyl transferase
10/17/2002WO2002038607A3 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor
10/17/2002WO2002036804A3 Method for detecting hematopoietic stem cells
10/17/2002WO2002036733A9 Cd36 as a heat shock protein receptor and uses thereof
10/17/2002WO2002029061A3 G-protein coupled receptors
10/17/2002WO2002022869A3 Directed evolution method
10/17/2002WO2002016417A3 Transgenic animal model for neurodegerative disease and uses thereof
10/17/2002WO2002015920A3 Treatment of hyperproliferative diseases
10/17/2002WO2002012854A9 Systems and methods for providing information concerning chromophores in physiological media
10/17/2002WO2002008420A3 A method of down-regulating gene expression
10/17/2002WO2002006806A3 Antioxidant sensor
10/17/2002WO2002004669A3 Improved capture and detection format versatility for dipstick assays
10/17/2002WO2002004489A9 Polymorphic kinase anchor proteins and nucleic acids encoding the same
10/17/2002WO2002000930A3 Method for dna extraction
10/17/2002WO2002000871A3 Method for introducing nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current
10/17/2002WO2001098354A3 Human receptors
10/17/2002WO2001098323A3 G-protein coupled receptors
10/17/2002WO2001094527A3 Preparing a sample to be analysed from a sample with very large volume
10/17/2002WO2001090151A3 Human receptor proteins; related reagents and methods
10/17/2002WO2001084148A3 Pharmacogenomics and identification of drug targets by reconstruction of signal transduction pathways based on sequences of accessible regions
10/17/2002WO2001079560A3 Medicine response assay in respiratory disease
10/17/2002WO2001077378A3 Diagnosis of diseases associated with dna adducts
10/17/2002WO2001061043A9 Parallel genotyping of multiple patient samples
10/17/2002WO2001061031A9 Improved assay for protein tyrosine phosphatases
10/17/2002WO2001059101A9 Method for amplifying full length single strand polynucleotide sequences
10/17/2002WO2001057275A9 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human brain
10/17/2002WO2001056216A9 Method, system and computer software for providing a genomic web portal
10/17/2002WO2001055444A9 Method for the evaluation of implantable materials
10/17/2002WO2001055410A9 Ceramidase compositions and methods based thereon
10/17/2002WO2001054712A9 Compositions and methods for the early diagnosis of ovarian cancer
10/17/2002WO2001040497A3 Method for obtaining nucleic acids from an environment sample
10/17/2002WO2001000138B1 Use of hydroxydiphenyl ether class of chemicals, as exemplified by triclosan, as an antimalarial and identification of fatty acid synthesis as its target
10/17/2002WO1998010097A3 Method and apparatus for single molecule two color fluorescent detection and molecular weight and concentration determination
10/17/2002US20020152485 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
10/17/2002US20020152481 Genetic engineering; qualitative analysis
10/17/2002US20020152035 Method and system for DNA mixture analysis
10/17/2002US20020151814 Detection of conditions by analysis of gases or vapours
10/17/2002US20020151725 Detecting phosphatidylcholine-specific phospholipase-C enzyme via incorporation of 3-indoxyl choline phosphate into substrate
10/17/2002US20020151711 Nucleotide compounds including a rigid linker
10/17/2002US20020151706 Antiinflammatory agents
10/17/2002US20020151700 Via analyzing parts of polynucleotide sequence of compound producing microorganism via genetic probes; gene expression
10/17/2002US20020151699 Transgenic; gene expression; cloning; isolation of ricinoleic acid from oleic acid in developing endosperm of castor
10/17/2002US20020151698 For diagnosis, prevention, and treatment of cancer, and neurological and immune disorders
10/17/2002US20020151695 Transforming growth factor-beta-related molecules and uses thereof
10/17/2002US20020151694 Release of intracellular material
10/17/2002US20020151677 Replikins and methods of identifying replikin-containing sequences
10/17/2002US20020151518 Oligonucleotide mediated specific sytokine induction and reduction of tumor growth in a mammal
10/17/2002US20020151515 Preparation and use of superior vaccines
10/17/2002US20020151514 Genes associated with mechanical stress, expression products therefrom, and uses thereof
10/17/2002US20020151511 Antisense oligonucleotide modulation of human MDM2 expression
10/17/2002US20020151498 Medicaments that modify activity of Lipolysis Stimulated Receptor and that can be used to influence partitioning of dietary lipids between liver and peripheral tissues, including adipose tissue
10/17/2002US20020151494 Novel amino acid sequences for human semaphorin-like polypeptides
10/17/2002US20020151488 G-CSF analog compositions and methods